Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | August 2026 | YoY |
|---|---|---|
| Revenue | 9.11k | 32.48% |
| Gross profit | -115.26k | 49.89% |
| Net profit | -414.93k | 48.92% |
| EBITDA | -414.57k | 48.96% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €17.37m |
Number of shares | 227.58m |
52-week high/low | €0.12 - €0.0445 |
| Dividends | No |
Beta | 0.29 |
P/E ratio | -7.10 |
PEG ratio | -0.83 |
P/B ratio | 6.36 |
P/S ratio | 537.03 |
Company profile
| Name | VOYAGEUR PHARMACEUTICALS |
| CEO | Brent Willis |
| Employees | 49 |
